Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cardinal Health Inc.

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Coeur Mining (CDE) and Evolution Mining (CAHPF). Co...

Analysts Offer Insights on Materials Companies: Coeur Mining (CDE) and Evolution Mining (OtherCAHPF)

Jarden analyst Ben Lyons maintained a Sell rating on Evolution Mining today and set a price target of A$8.20. Lyons covers the Basic Materials sect...

Jarden Keeps Their Sell Rating on Evolution Mining  (CAHPF)

In a report released today, Adam Baker from Macquarie maintained a Hold rating on Evolution Mining , with a price target of A$11.50. Baker covers t...

Macquarie Reaffirms Their Hold Rating on Evolution Mining  (CAHPF)

In a report released today, David Coates from Bell Potter maintained a Buy rating on Evolution Mining , with a price target of A$15.10. Coates cove...

Evolution Mining  (CAHPF) Receives a Buy from Bell Potter

In a report released today, Paul Kaner from Ord Minnett maintained a Buy rating on Evolution Mining , with a price target of A$12.80. According to ...

Ord Minnett Keeps Their Buy Rating on Evolution Mining  (CAHPF)

Analysts have been eager to weigh in on the Materials sector with new ratings on Rio Tinto Limited (RTNTF) and Evolution Mining (CAHPF). Rio Tinto ...

Analysts Conflicted on These Materials Names: Rio Tinto Limited (OtherRTNTF) and Evolution Mining (OtherCAHPF)

Citi analyst Jack Whelan maintained a Hold rating on Evolution Mining today and set a price target of A$15.00. According to TipRanks, Whelan is an ...

Evolution Mining  (CAHPF) Gets a Hold from Citi

In a report released today, Levi Spry from UBS maintained a Hold rating on Evolution Mining , with a price target of A$12.00. Spry covers the Basic...

Evolution Mining  (CAHPF) Gets a Hold from UBS

In a report released today, Brian Quast from BMO Capital maintained a Hold rating on Evolution Mining , with a price target of A$15.00. Quast cover...

BMO Capital Remains a Hold on Evolution Mining  (CAHPF)

In a report released today, Annabelle Sleeman from Morgans maintained a Buy rating on Evolution Mining , with a price target of A$16.00. According ...

Morgans Reaffirms Their Buy Rating on Evolution Mining  (CAHPF)

UBS analyst Levi Spry maintained a Hold rating on Evolution Mining today and set a price target of A$12.20. According to TipRanks, Spry is a 5-star...

Evolution Mining  (CAHPF) Receives a Hold from UBS

Evolution Mining received a Hold rating and a A$12.00 price target from Macquarie analyst Adam Baker today. Baker covers the Basic Materials sector...

Macquarie downgrades Evolution Mining  (CAHPF) to a Hold

Evolution Mining received a Hold rating and a A$12.60 price target from UBS analyst Levi Spry today. Spry covers the Basic Materials sector, focusi...

UBS downgrades Evolution Mining  (CAHPF) to a Hold

Morgans analyst Annabelle Sleeman maintained a Buy rating on Evolution Mining today and set a price target of A$15.00. Sleeman covers the Basic Mat...

Morgans Sticks to Their Buy Rating for Evolution Mining  (CAHPF)

Evolution Mining ( ($AU:EVN) ) has shared an announcement. Evolution Mining will release its quarterly report for the period ended 30 June 2026 to ...

Evolution Mining sets July 15 call to unveil June quarter results

Stocks ended the week lower as investors pulled back from risk assets and rotated into safer parts of the market. The Dow Jones Industrial Average ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CAH	$228.52	-0.09%	2.05M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CAH	$228.52	-0.1%	2.05M
3
4
5
6

CAH

CAH

Get Cardinal Health Inc. Data in Excel

Get Cardinal Health Inc. Data in Excel